Exclusive Zantac-Related Breast Cancer Leads that are Ready to Litigate
Zantac and Breast Cancer A peer-reviewed study by the American Association for Cancer Research examined the relationship between Zantac and breast cancer. Obtaining solid cases involving breast cancer by Zantac users might be the hardest task facing a plaintiff law firm.” — Edward Lott,Ph.D., M.B.A. ALLENTOWN, PA, US, August 13, 2020 /EINPresswire.com/ -- ForLawFirmsOnly Marketing, Inc., helps law firms handling personal injury cases or class action lawsuits attract clients. These firms not only want to be profitable, they help their communities. A peer-reviewed study by the American Association for Cancer Research and the American Society of Preventive Oncology examined the relationship between H2 antihistamine-blockers like Zantac and breast cancer. Zantac is a histamine H2-receptor antagonist, also known as an H2 blocker. Ranitidine increases the levels of the hormone prolactin. A study found chances of a type of ductal carcinoma increase with the use of ranitidine. How does it work?